Business Information
The company's principal activities are research, development, production and clinical testing of medical products based on its proprietary protein-based biomaterials technology. The products of the company are surgical repairs of tissue, surgical adhesives and sealants, soft tissue augmentation products, wound healing matrices, drug delivery formulations and surgical adhesion barriers. The company's operations have been directed primarily toward developing business strategies, raising capital, research and development activities, conducting clinical testing of the product candidates, exploring marketing channels and recruiting personnel. The company focuses on the development materials technology and products to be used in the surgical repair of tissue, surgical adhesives and sealants, soft tissue augmentation products, wound healing matrices, drug delivery formulations and surgical adhesion barriers.
|
|
Name |
Title
|
Email
|
| James McCarthy | Chmn., CEO | N/A | | Joseph Cappello | CTO, VP - Research, Development | N/A | | Franco Ferrari | VP - Laboratory Operations, Polymer Production, Dir. - Molecular Genetics | N/A | | Allan Farber | Dir. | N/A | | Kerry Kuhn | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 605 | (7,878) | | 2005 | 867 | (5,822) | | 2004 | 457 | (3,565)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
